Zoletil 50, 125 mg + 125 mg, liofilizatas ir tirpiklis injekciniam tirpalui ruošti šunims ir katėms
Zoletil 50, 125 mg + 125 mg, liofilizatas ir tirpiklis injekciniam tirpalui ruošti šunims ir katėms
Authorised
- Zolazepam hydrochloride
- Tiletamine hydrochloride
Product identification
Medicine name:
Zoletil 50, 125 mg + 125 mg, liofilizatas ir tirpiklis injekciniam tirpalui ruošti šunims ir katėms
Active substance:
- Zolazepam hydrochloride
- Tiletamine hydrochloride
Target species:
-
Dog
-
Cat
Route of administration:
-
Intravenous use
-
Intramuscular use
Product details
Active substance and strength:
-
Zolazepam hydrochloride125.00/milligram(s)1.00Vial
-
Tiletamine hydrochloride125.00/milligram(s)1.00Vial
Pharmaceutical form:
-
Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Dog
-
Not applicable0day
-
-
-
Intramuscular use
-
Cat
-
Not applicable0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01AX99
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/05/1691/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Lithuanian (PDF)
Published on: 12/10/2023